Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Sep;15(5):419-428.
doi: 10.2217/pme-2018-0022. Epub 2018 Sep 27.

Reconceptualizing harms and benefits in the genomic age

Anya E R Prince  1 , Benjamin E Berkman  2
Affiliations
Editorial

Reconceptualizing harms and benefits in the genomic age

Anya E R Prince et al. Per Med. 2018 Sep.

Abstract

As new, high-powered sequencing technologies are increasingly incorporated into genomics research, we believe that there has been a break point in how risks and benefits associated with genetic information are being characterized and understood. Genomic sequencing provides the potential benefit of a wealth of information, but also has the potential to alter how we conceptualize risks of sequencing. Until now, our conceptions of risks and benefits have been generally static, arising out of the early ethical, legal and social implications studies conducted in the context of targeted genetics. This paper investigates how the increasing availability of genetic information is changing views about risks and benefits, particularly examining our evolving understanding of psychosocial harms and our expanding conception of benefit. We argue that the lack of robust empirical evidence of psychosocial harms and the expanding view that benefits of genomic research include indirect familial benefit necessitate continued ethical, legal and social implications research.

Keywords: ELSI; genomics research; next-generation sequencing; research ethics; risks and benefits.

PubMed Disclaimer

References

    1. Henderson GE, Wolf SM, Kuczynski KJ et al. The challenge of informed consent and return of results in translational genomics: empirical analysis and recommendations. J. Law Med. Ethics 42(3), 344–355 (2014). - PMC - PubMed
    1. Rew L, Kaur M, Mcmillan A, Mackert M, Bonevac D. Systematic review of psychosocial benefits and harms of genetic testing. Issues Ment. Health Nurs 31(10), 631–645 (2010). - PubMed
    1. Lerman C, Croyle RT, Tercyak KP, Hamann H. Genetic testing: psychological aspects and implications. J. Consult. Clin. Psychol 70(3), 784 (2002). - PubMed
    1. Cameron LD, Muller C. Psychosocial aspects of genetic testing. Curr. Opin. Psychiatry 22(2), 218–223 (2009). - PubMed
    1. Wahlin T-BR. To know or not to know: a review of behaviour and suicidal ideation in preclinical Huntington’s disease. Patient Educ. Couns 65(3), 279–287 (2007). - PubMed

Publication types